Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study.
Ruth A. Mulnard(University of California, Irvine), Leon J. Thal(Johns Hopkins University)
Cited by 987
Related Papers
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
|New England Journal of Medicine|1997|2.4k
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
|Neurology|2009|739
Identification of genetic risk factors in the Chinese population implicates a role of immune system in Alzheimer’s disease pathogenesis
|Proceedings of the National Academy of Sciences|2018|103